These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26091361)

  • 1. Evaluation of the Transwell System for Characterization of Dissolution Behavior of Inhalation Drugs: Effects of Membrane and Surfactant.
    Rohrschneider M; Bhagwat S; Krampe R; Michler V; Breitkreutz J; Hochhaus G
    Mol Pharm; 2015 Aug; 12(8):2618-24. PubMed ID: 26091361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers.
    Bhagwat S; Schilling U; Chen MJ; Wei X; Delvadia R; Absar M; Saluja B; Hochhaus G
    Pharm Res; 2017 Dec; 34(12):2541-2556. PubMed ID: 28799097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation.
    Fu TT; Zhao Y; Yang FF; Wen H; Liu CY; Liao YH
    Int J Pharm; 2018 Oct; 549(1-2):21-30. PubMed ID: 30048776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
    Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
    Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo-Relevant Transwell Dish-Based Dissolution Testing for Orally Inhaled Corticosteroid Products.
    Sakagami M; Li H; Venitz J
    Pharm Res; 2019 May; 36(7):95. PubMed ID: 31073686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
    Kramer S; Rottier BL; Scholten RJ; Boluyt N
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD010352. PubMed ID: 23450613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro aqueous fluid-capacity-limited dissolution testing of respirable aerosol drug particles generated from inhaler products.
    Arora D; Shah KA; Halquist MS; Sakagami M
    Pharm Res; 2010 May; 27(5):786-95. PubMed ID: 20229134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Membrane-Type Dissolution Profiles of Clinically Available Orally Inhaled Products Using a Weibull Fit and a Mechanistic Model.
    van der Zwaan I; Franek F; Fransson R; Tehler U; Frenning G
    Mol Pharm; 2022 Sep; 19(9):3114-3124. PubMed ID: 35939615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution- and absorption rates in the lungs.
    Malmlöf M; Nowenwik M; Meelich K; Rådberg I; Selg E; Burns J; Mascher H; Gerde P
    Eur J Pharm Biopharm; 2019 Jun; 139():213-223. PubMed ID: 30862480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
    Janson C; Stratelis G; Miller-Larsson A; Harrison TW; Larsson K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3055-3064. PubMed ID: 29089754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranking in Vitro Dissolution of Inhaled Micronized Drug Powders including a Candidate Drug with Two Different Particle Sizes.
    Franek F; Fransson R; Thörn H; Bäckman P; Andersson PU; Tehler U
    Mol Pharm; 2018 Nov; 15(11):5319-5326. PubMed ID: 30299965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro evaluation of four corticosteroid metered dose inhalers: Consistency of delivered dose and particle size distribution.
    de Vries TW; Rottier BL; Gjaltema D; Hagedoorn P; Frijlink HW; de Boer AH
    Respir Med; 2009 Aug; 103(8):1167-73. PubMed ID: 19269801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products.
    Price R; Shur J; Ganley W; Farias G; Fotaki N; Conti DS; Delvadia R; Absar M; Saluja B; Lee S
    AAPS J; 2020 Feb; 22(2):47. PubMed ID: 32060670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs.
    Hartung N; Borghardt JM
    PLoS Comput Biol; 2020 Dec; 16(12):e1008466. PubMed ID: 33320846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.
    Gulliver T; Morton R; Eid N
    Paediatr Drugs; 2007; 9(3):185-94. PubMed ID: 17523699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique.
    Bur M; Huwer H; Muys L; Lehr CM
    J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):119-27. PubMed ID: 20073555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the Transwell
    Amini E; Kurumaddali A; Bhagwat S; Berger SM; Hochhaus G
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of drug dissolution and uptake from low-density DPI formulations in an impactor-integrated cell culture model.
    Šimková K; Thormann U; Imanidis G
    Eur J Pharm Biopharm; 2020 Oct; 155():12-21. PubMed ID: 32717388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel method for assessing dissolution of aerosol inhaler products.
    Davies NM; Feddah MR
    Int J Pharm; 2003 Apr; 255(1-2):175-87. PubMed ID: 12672613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.